| Phase 15 trials |
|
Phase 1
|
NCT00607841 |
Dec 2007 → Nov 2009 |
breast cancer |
Cytokinetics |
Terminated
|
No outcome recorded
|
|
Phase 1
|
NCT00363272 |
Jun 2006 → Oct 2008 |
Burkitt lymphoma, cerebellar astrocytoma, childhood brain stem glioma, childhood central nervous system germ cell tumor +13 |
National Cancer Institute (NCI) |
Completed
|
No outcome recorded
|
|
Phase 1
|
NCT00098826 |
Dec 2004 → May 2008 |
acute erythroid leukemia, acute megakaryoblastic leukemia in adult, acute myeloblastic leukemia with maturation, acute myeloblastic leukemia without maturation +13 |
National Cancer Institute (NCI) |
Completed
|
No outcome recorded
|
|
Phase 1
|
NCT00101244 |
Nov 2004 → Feb 2010 |
Burkitt lymphoma, Hodgkins lymphoma, MALT lymphoma, Waldenstrom macroglobulinemia +7 |
National Cancer Institute (NCI) |
Terminated
|
No outcome recorded
|
|
Phase 1
|
NCT00119171 |
Nov 2004 → ? |
— |
GlaxoSmithKline |
Completed
|
No outcome recorded
|
| Phase 29 trials |
|
Phase 2
|
NCT00354250 |
May 2006 → Feb 2007 |
renal cell carcinoma |
National Cancer Institute (NCI) |
Completed
|
No outcome recorded
|
|
Phase 2
|
NCT00096499 |
Apr 2005 → Jan 2007 |
prostate adenocarcinoma |
National Cancer Institute (NCI) |
Completed
|
No outcome recorded
|
|
Phase 2
|
NCT00095992 |
Mar 2005 → Sep 2006 |
liver cancer |
NCIC Clinical Trials Group |
Completed
|
No outcome recorded
|
|
Phase 2
|
NCT00095628 |
Jan 2005 → Jul 2010 |
hypopharynx squamous cell carcinoma, larynx verrucous carcinoma, metastatic squamous cell carcinoma, nasal cavity and paranasal sinus squamous cell carcinoma +3 |
National Cancer Institute (NCI) |
Completed
|
No outcome recorded
|
|
Phase 2
|
NCT00103311 |
Jan 2005 → Jan 2010 |
malignant colon neoplasm, metastatic malignant neoplasm in the colon, rectal carcinoma |
National Cancer Institute (NCI) |
Completed
|
No outcome recorded
|
|
Phase 2
|
NCT00097409 |
Dec 2004 → May 2007 |
ovarian cancer |
GlaxoSmithKline |
Completed
|
No outcome recorded
|
|
Phase 2
|
NCT00095953 |
Nov 2004 → Sep 2006 |
cutaneous melanoma |
NCIC Clinical Trials Group |
Completed
|
No outcome recorded
|
|
Phase 2
|
NCT00089973 |
Jun 2004 → Aug 2006 |
breast neoplasm |
GlaxoSmithKline |
Completed
|
No outcome recorded
|
|
Phase 2
|
NCT00085813 |
Dec 2003 → Oct 2005 |
non-small cell lung carcinoma |
GlaxoSmithKline |
Completed
|
No outcome recorded
|